Editor's Choice - The Abdominal Aortic Aneurysm Get Fit Trial: A Randomised Controlled Trial of Exercise to Improve Fitness in Patients with Abdominal Aortic Aneurysm

被引:9
|
作者
Haque, Adam [1 ,2 ]
Wisely, Nicholas [1 ,3 ]
McCollum, Charles [1 ]
机构
[1] Univ Manchester, Oxford Rd, Manchester, Lancs, England
[2] Manchester Univ NHS Fdn Trust, Manchester Vasc Ctr, Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, Lancs, England
[3] Manchester Univ NHS Fdn Trust, Dept Anaesthesia, Wythenshawe Hosp, Southmoor Rd, Manchester, Lancs, England
关键词
Abdominal aortic aneurysm; Cardiopulmonary exercise testing; Cardiopulmonary fitness; Exercise training; Peri-operative medicine; Prehabilitation; MORTALITY; RISK; OUTCOMES; UPDATE; REPAIR;
D O I
10.1016/j.ejvs.2022.07.005
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Ruptured abdominal aortic aneurysm (AAA) carries a mortality rate of up to 80%. Elective repair prevents rupture, but peri-operativemortality remains at 2% - 3%. Thismortality rate and long termsurvival rate are associated with impaired peak oxygen uptake (peak VO2), oxygen uptake at anaerobic threshold (AT) and ventilatory equivalent for CO2 (VECO2) at ATon cardiopulmonary exercise testing (CPET). Improving fitness to optimise these variables could improve peri-operative and long termsurvival, but the required exercise training suitable for patients with AAA has yet to be established. This randomised controlled trial aimed to evaluate the effectiveness of 24 week, patient directed, community based exercise on CPETmeasured fitness in AAA surveillance patients. Methods: This was a prospective randomised controlled trial in a tertiary UK vascular centre conducted using CONSORT guidelines. Patients on AAA surveillance (n = 56) were randomly assigned to either (1) a 24 week community exercise programme (CEP) with choice of gym or home exercises, or (2) standard clinical care including advice on weight loss and exercise. The primary outcome was change in peak VO2 at 24 weeks, with secondary outcomes including AT, VECO2, cardiovascular biomarkers (lipid profile, pro-B-type natriuretic peptide, and high sensitivity C reactive protein, body mass index, and HRQoL. Follow up was at eight, 16, 24, and 36 weeks to evaluate duration of benefit. All analyses were performed on an intention to treat basis. Results: CEP patients (n = 28) achievedmean (95% confidence interval [CI]) improvements frombaseline in peak VO2 of 1.5 (95% CI 0.5-2.5), 2.1 (95% CI 1.1-3.2), 2.3 (95% CI 1.2-3.3), and 2.2 (95% CI 1.1, 3.3) mL/kg/min at 8, 16, 24, and 36 weeks, respectively. These changes in CEP patients were significantly greater than those seen in control patients at 16 (p =.002), 24 (p =.031), and 36 weeks (p <.001). There were also significant improvements in AT, triglyceride levels, and HRQoL in CEP patients. Conclusion: This CEP significantly improved those CPET parameters associated with impaired peri-operative and long term survival in patients following AAA repair. These improvements were maintained at 12 weeks following the end of the programme.
引用
收藏
页码:309 / 319
页数:11
相关论文
共 50 条
  • [21] A Randomised Controlled Trial Assessing the Effects of Peri-operative Fenofibrate Administration on Abdominal Aortic Aneurysm Pathology: Outcomes From the FAME Trial
    Moxon, Joseph, V
    Rowbotham, Sophie E.
    Pinchbeck, Jenna L.
    Lazzaroni, Sharon M.
    Morton, Susan K.
    Moran, Corey S.
    Quigley, Frank
    Jenkins, Jason S.
    Reid, Christopher M.
    Cavaye, Doug
    Jaeggi, Rene
    Golledge, Jonathan
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2020, 60 (03) : 452 - 460
  • [22] Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm
    Golledge, Jonathan
    Arnott, Clare
    Moxon, Joseph
    Monaghan, Helen
    Norman, Richard
    Morris, Dylan
    Li, Qiang
    Jones, Greg
    Roake, Justin
    Bown, Matt
    Neal, Bruce
    TRIALS, 2021, 22 (01)
  • [23] Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm
    Jonathan Golledge
    Clare Arnott
    Joseph Moxon
    Helen Monaghan
    Richard Norman
    Dylan Morris
    Qiang Li
    Greg Jones
    Justin Roake
    Matt Bown
    Bruce Neal
    Trials, 22
  • [24] Variation in the choice of elective surgical procedure for abdominal aortic aneurysm in Spain
    Jesus Quintana, M.
    Gich, Ignasi
    Librero, Julian
    Bellmunt-Montoya, Sergi
    Escudero, Jose R.
    Bonfill, Xavier
    Jesus Quintana, M.
    Escudero, Jose R.
    Bellmunt, Sergi
    Plana, Nieves
    Muriel, Alfonso
    Castejon, Borja
    Miralles, Manuel
    Galvez Nunez, Laura
    Morales-Suarez-Varela, Maria M.
    Fernandez de Valderrama, Ines
    Isabel Rodriguez, Ana
    Gomez de la Camara, Agustin
    Ignacio Pijoan, Jose
    Perez, Eduardo
    VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 69 - 79
  • [25] Editor's Choice - Trend-break in Abdominal Aortic Aneurysm Repair With Decreasing Surgical Workload
    Lilja, F.
    Mani, K.
    Wanhainen, A.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2017, 53 (06) : 811 - 819
  • [26] TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
    Morris, Dylan R.
    Cunningham, Margaret A.
    Ahimastos, Anna A.
    Kingwell, Bronwyn A.
    Pappas, Elise
    Bourke, Michael
    Reid, Christopher M.
    Stijnen, Theo
    Dalman, Ronald L.
    Aalami, Oliver O.
    Lindeman, Jan H.
    Norman, Paul E.
    Walker, Philip J.
    Fitridge, Robert
    Bourke, Bernie
    Dear, Anthony E.
    Pinchbeck, Jenna
    Jaeggi, Rene
    Golledge, Jonathan
    TRIALS, 2015, 16
  • [27] TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
    Dylan R. Morris
    Margaret A. Cunningham
    Anna A. Ahimastos
    Bronwyn A. Kingwell
    Elise Pappas
    Michael Bourke
    Christopher M. Reid
    Theo Stijnen
    Ronald L. Dalman
    Oliver O. Aalami
    Jan H. Lindeman
    Paul E. Norman
    Philip J. Walker
    Robert Fitridge
    Bernie Bourke
    Anthony E. Dear
    Jenna Pinchbeck
    Rene Jaeggi
    Jonathan Golledge
    Trials, 16
  • [28] Endovascular Aneurysm Repair Is Not the Treatment of Choice in Most Patients with Ruptured Abdominal Aortic Aneurysm
    Livesay, James J.
    Talledo, Oscar G.
    TEXAS HEART INSTITUTE JOURNAL, 2013, 40 (05) : 556 - 559
  • [29] Cardiopulmonary exercise testing and survival after elective abdominal aortic aneurysm repair
    Grant, S. W.
    Hickey, G. L.
    Wisely, N. A.
    Carlson, E. D.
    Hartley, R. A.
    Pichel, A. C.
    Atkinson, D.
    McCollum, C. N.
    BRITISH JOURNAL OF ANAESTHESIA, 2015, 114 (03) : 430 - 436
  • [30] Frailty in patients with abdominal aortic aneurysm predicts prognosis after elective endovascular aneurysm repair
    Morisaki, Koichi
    Furuyama, Tadashi
    Yoshiya, Keiji
    Kurose, Shun
    Yoshino, Shinichiro
    Nakayama, Ken
    Yamashita, Sho
    Kawakubo, Eisuke
    Matsumoto, Takuya
    Mori, Masaki
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (01) : 138 - 143